Exhibit 10.1


 


Execution Version


 


$500,000,000


 


ENVESTNET, INC.


 


2.625% Convertible Notes due 2027


 





 



 


Purchase Agreement


 


November 14, 2022


 


Morgan Stanley & Co. LLC


BofA Securities, Inc.


BMO Capital Markets Corp.


J.P. Morgan Securities LLC


 


As representatives (the “Representatives”)
of the several Purchasers


named in Schedule I hereto,


 


c/o Morgan Stanley & Co. LLC


1585 Broadway


New York, New York 10036


 


Ladies and Gentlemen:


 


Envestnet, Inc., a Delaware
corporation (the “Company”), proposes, subject to the terms and conditions set forth in this agreement (this “Agreement”),
to issue and sell to the entities named in Schedule I hereto (the “Purchasers”), for whom you (the “Representatives”)
are acting as representatives, an aggregate of $500,000,000 principal amount of its 2.625% Convertible Notes due 2027, convertible into
the common stock, par value $0.005 per share (the “Stock”), of the Company (the “Firm Notes”) and, at the election
of the Purchasers, up to an aggregate of $75,000,000 additional principal amount of the Company’s 2.625% Convertible Notes due 2027
solely to cover overallotments (the “Optional Notes”). The Firm Notes and the Optional Notes that the Purchasers elect to
purchase pursuant to Section 2 hereof are herein collectively called the “Notes.” The Company’s obligations under the
Notes will be fully and unconditionally guaranteed (the “Guarantee”) on an unsecured basis by Envestnet Asset Management,
Inc., a Delaware corporation (the “Guarantor”), and a wholly-owned subsidiary of the Company. The Notes and the Guarantee
are collectively referred to herein as the “Securities.” The Notes and the Guarantee are to be issued pursuant to an indenture
to be dated as of November 17, 2022 (the “Indenture”), by and among the Company, the Guarantor and U.S. Bank Trust Company,
National Association, as trustee (the “Trustee”).


 






     


     


    

 


In connection with the offering
of Firm Notes, the Company is entering into capped call transactions with one or more counterparties, which may include Purchasers or
their affiliates and/or other financial institutions (the “Option Counterparties”) covering the number of shares of Stock
underlying the Firm Notes pursuant to capped call confirmations (the “Base Capped Call Confirmations”), each dated the date
hereof, and in connection with the exercise by the Purchasers of their option to purchase any Optional Notes, the Company and the Option
Counterparties may enter into additional capped call transactions pursuant to additional capped call confirmations (the “Additional
Capped Call Confirmations”), each dated the date on the which the Purchasers exercise their option to purchase such Optional Notes.
The Base Capped Call Confirmations and the Additional Capped Call Confirmations are collectively referred to herein as the “Capped
Call Confirmations.”


 


The sale of the Securities
to the Purchasers will be made without registration of the Securities or the Stock issuable upon conversion thereof under the Securities
Act of 1933, as amended (the “Securities Act”), in reliance upon exemptions from the registration requirements of the Securities
Act. The Representatives have advised the Company that the Purchasers will offer and sell the Securities purchased by them hereunder in
accordance with Section 6 hereof as soon as the Representatives deem advisable.


 


In connection with the offering
of the Securities, the Company has prepared a preliminary offering memorandum, dated November 14, 2022 (the “Preliminary Offering
Memorandum”). Promptly after the execution of this Agreement, the Company will prepare and deliver to the Purchasers an offering
memorandum (the “Offering Memorandum”) relating to the offering of the Securities which will consist of the information in
the Preliminary Offering Memorandum with such changes therein as are required to reflect the information set forth in Schedule III hereto.


 


Any reference to the Preliminary
Offering Memorandum, the Pricing Disclosure Package (as defined in Section 1(b)) or the Offering Memorandum (or to any information “contained,”
“included” or “stated” (or other references of like import) in the Preliminary Offering Memorandum, the Pricing
Disclosure Package or the Offering Memorandum) shall be deemed to refer to and include all documents filed with the U.S. Securities and
Exchange Commission (the “Commission”) pursuant to Section 13(a), 13(c) or 15(d) of the Securities Exchange Act of 1934, as
amended (the “Exchange Act”), on or prior to the date of the Preliminary Offering Memorandum, the Pricing Disclosure Package
or the Offering Memorandum, as the case may be, and incorporated by reference therein; and reference to the Preliminary Offering Memorandum,
the Pricing Disclosure Package or the Offering Memorandum, as the case may be, as amended or supplemented, as of any specified date, shall
be deemed to include (i) any documents filed with the Commission pursuant to Section 13(a), 13(c) or 15(d) of the Exchange Act after the
date of the Preliminary Offering Memorandum, the Pricing Disclosure Package or the Offering Memorandum, as the case may be, and prior
to such specified date and (ii) any Additional Issuer Information (as defined in Section 5(e)) furnished by the Company or the Guarantor
prior to the completion of the distribution of the Securities.


 


		1.	The Company and the Guarantor, jointly and severally, represent and warrant to, and agree with, each of
the Purchasers that:



 


		(a)	The Preliminary Offering Memorandum or the Offering Memorandum and any amendments or supplements thereto
did not and will not, as of their respective dates, contain an untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided,
however, that this representation and warranty shall not apply to any statements or omissions made in reliance upon and in conformity
with the Purchasers’ Information (as defined in Section 9(a));



 






    2


     


    

 


		(b)	For the purposes of this Agreement, the “Applicable Time” is 11:45 p.m. (New York City time)
on the date of this Agreement. The Preliminary Offering Memorandum, as supplemented by the information set forth in Schedule III hereto,
taken together (collectively, the “Pricing Disclosure Package”), as of the Applicable Time, did not include any untrue statement
of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; and each Company Supplemental Disclosure Document (as defined in Section 6(a) and listed on
Schedule II(a) hereto) did not, as of its date of issue, conflict with the information contained in the Preliminary Offering Memorandum
or the Offering Memorandum and each Company Supplemental Disclosure Document, as supplemented by and taken together with the Pricing Disclosure
Package as of the Applicable Time, did not include any untrue statement of a material fact or omit to state any material fact necessary
in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however
that this representation and warranty shall not apply to statements or omissions made in the Preliminary Offering Memorandum, the Pricing
Disclosure Package or in a Company Supplemental Disclosure Document, in each case in reliance upon and in conformity with the Purchasers’
Information;



 


		(c)	The documents incorporated by reference in the Pricing Disclosure Package and the Offering Memorandum,
when they were filed with the Commission, conformed in all material respects to the requirements of the Exchange Act, and the rules and
regulations of the Commission thereunder, and none of such incorporated documents contained an untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading;



 


		(d)	Neither the Company nor any of its subsidiaries has sustained since the date of the latest audited financial
statements included or incorporated by reference in the Pricing Disclosure Package any material loss or interference with its business,
direct or contingent, including from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor
dispute or court or governmental action, order or decree, otherwise than as described or contemplated in the Pricing Disclosure Package;
and, since the respective dates as of which information is given in the Pricing Disclosure Package, (i) the Company and its subsidiaries
have not incurred any material liability or obligation, direct or contingent, nor entered into any material transaction; (ii) the Company
has not purchased any of its outstanding capital stock, nor declared, paid or otherwise made any dividend or distribution of any kind
on its capital stock (iii) there has not been any change in the capital stock, short-term debt or long-term debt of the Company or any
of its subsidiaries, taken as a whole, other than, in the case of clauses (i), (ii) and (iii), changes described or contemplated in the
Pricing Disclosure Package; and (iv) there has not been any material adverse change in the condition, financial or otherwise, or in the
earnings, business or operations of the Company and its subsidiaries, taken as a whole (a “Material Adverse Effect”);



 


		(e)	The Company and its subsidiaries have good and marketable title to all property owned by them which is
material to the business of the Company and its subsidiaries, in each case free and clear of all liens, encumbrances and defects except
such as are described in the Pricing Disclosure Package or such as do not materially affect the value of such property and do not interfere
with the use made and proposed to be made of such property by the Company and its subsidiaries; and any real property and buildings held
under lease by the Company and its subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as
are not material and do not materially interfere with the use made and proposed to be made of such property and buildings by the Company
and its subsidiaries, in each case except as described in the Pricing Disclosure Package;



 






    3


     


    

 


		(f)	The Company and its subsidiaries (i) are in compliance with any and all applicable foreign, federal, state
and local laws and regulations relating to the protection of human health and safety, the environment or hazardous or toxic substances
or wastes, pollutants or contaminants (“Environmental Laws”), (ii) have received all permits, licenses or other approvals
required of them under applicable Environmental Laws to conduct their respective businesses and (iii) are in compliance with all terms
and conditions of any such permit, license or approval, except where such noncompliance with Environmental Laws, failure to receive required
permits, licenses or other approvals or failure to comply with the terms and conditions of such permits, licenses or approvals would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect; there are no costs or liabilities associated
with Environmental Laws (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties
or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating activities and any potential
liabilities to third parties) which would, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect;



 


		(g)	The Company (i) has been duly incorporated and is validly existing as a corporation in good standing under
the laws of the State of Delaware, with corporate power and corporate authority to own its properties and conduct its business as described
in the Pricing Disclosure Package, and (ii) has been duly qualified as a foreign corporation for the transaction of business and is in
good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business so as to require
such qualification, except in the case of clause (ii), where the failure to be so qualified or in good standing would not have a Material
Adverse Effect; and each subsidiary of the Company (including the Guarantor) (x) has been duly incorporated or formed, as the case may
be, and is validly existing as a corporation or limited liability company, as applicable, in good standing under the laws of its jurisdiction
of incorporation or formation, with the company power and authority to own its properties and conduct its business as described in the
Pricing Disclosure Package, and (y) has been duly qualified as a foreign corporation or limited liability company for the transaction
of business and is in good standing under the laws of each other jurisdiction in which it owns or leases properties or conducts any business
so as to require such qualification, except in the case of clause (y), where the failure to be so qualified or in good standing would
not have a Material Adverse Effect;



 


		(h)	The Company has an authorized capitalization as set forth in the Pricing Disclosure Package under the
captions “Capitalization” and “Description of Capital Stock” and all of the issued shares of capital stock of
the Company have been duly authorized and validly issued and are fully paid and non-assessable and conform in all material respects to
the description of the Stock contained in the Pricing Disclosure Package under the captions “Capitalization” and “Description
of Capital Stock”; and all of the issued shares of capital stock of each subsidiary of the Company have been duly authorized and
validly issued, are fully paid and non-assessable and (except for directors’ qualifying shares) are owned directly or indirectly
by the Company, free and clear of all liens, encumbrances, equities or claims;



 


		(i)	The execution and delivery of this Agreement, the Indenture, the Notes, the Guarantee and the Capped Call
Confirmations by the Company and the Guarantor, as applicable, the performance by the Company and the Guarantor of their respective obligations
under this Agreement, the Indenture, the Notes, the Guarantee and the Capped Call Confirmations, as applicable, and the consummation of
the transactions herein and therein contemplated (A) will not conflict with or result in a breach or violation of any of the terms or
provisions of, or constitute a default under, any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument
to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries is bound or to which any
of the property or assets of the Company or any of its subsidiaries is subject, except for any such conflicts, breaches, violations or
defaults that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect, (B) will not violate
any of the provisions of the Certificate of Incorporation or Bylaws of the Company, the Certificate of Incorporation or Bylaws of the
Guarantor or the organizational documents of any other subsidiary of the Company, (C) will not violate any statute or any order, rule
or regulation of any court or governmental agency or body having jurisdiction over the Company or any of its subsidiaries or any of their
properties, except for any such violations that would not, individually or in the aggregate, reasonably be expected to have a Material
Adverse Effect and (D) will not require any consent, approval, authorization, order, registration or qualification of or with any court,
governmental agency or body or third party, except for such consents, approvals, authorizations, orders, registrations or qualifications
as may be required under state securities or Blue Sky laws in connection with the purchase and distribution of the Securities by the Purchasers;



 






    4


     


    

 


		(j)	Neither the Company nor any of its subsidiaries is (A) in violation of its Certificate of Incorporation,
Bylaws or other organizational documents or (B) in default in the performance or observance of any obligation, agreement, covenant or
condition contained in any indenture, mortgage, deed of trust, loan agreement, lease or other agreement or instrument to which it is a
party or by which it or any of its properties may be bound, except in the case of clause (B), to the extent that such default would not
have a Material Adverse Effect;



 


		(k)	The statements set forth (A) in the Pricing Disclosure Package and the Offering Memorandum under the caption
“Description of Capital Stock,” insofar as they purport to constitute a summary of the terms of the Stock, (B) in the Pricing
Disclosure Package and the Offering Memorandum under the caption “Description of the Notes,” insofar as they purport to constitute
a summary of the terms of the Securities or the Indenture, (C) in the Pricing Disclosure Package and the Offering Memorandum under the
caption “Description of Capped Call Transactions,” insofar as they purport to constitute a summary of the terms of the Capped
Call Confirmations and (D) in the Pricing Disclosure Package and the Offering Memorandum under the captions “Material United States
Federal Tax Considerations” and “Plan of Distribution,” and in the Company’s Annual Report on Form 10-K for the
year ended December 31, 2021 under the caption “Item 1. Business—Regulation,” insofar as they purport to describe the
provisions of the laws, matters and documents referred to therein, fairly summarize in all material respects such terms, laws, matters
and documents;



 


		(l)	Other than as set forth in the Pricing Disclosure Package, there are no legal or governmental proceedings
pending to which the Company or any of its subsidiaries is a party or of which any property or assets of the Company or any of its subsidiaries
is the subject which (A) if determined adversely to the Company or any of its subsidiaries or any officer or director, would individually
or in the aggregate reasonably be expected to have a Material Adverse Effect or materially adversely affect the power or ability of the
Company to perform its obligations under this Agreement or to consummate the transactions contemplated by the Pricing Disclosure Package
or (B) would be required by the Securities Act to be described in a registration statement on Form S-1 to be filed with the Commission
if the offer and sale of the Securities contemplated hereunder were made pursuant to such registration statement that have not been described
in each of the Pricing Disclosure Package and the Offering Memorandum; and, to the Company’s and the Guarantor’s knowledge,
no such proceedings are threatened by governmental authorities or threatened by others;



 


		(m)	Each of the Company and the Guarantor is not and, after giving effect to the offering and sale of the
Securities, the application of the proceeds thereof and the transactions contemplated by the Capped Call Confirmations, will not be required
to register as an “investment company” under the Investment Company Act of 1940, as amended (the “Investment Company
Act”);



 


		(n)	KPMG LLP, who have audited certain financial statements of the Company and its subsidiaries, are independent
certified public accountants with respect to the Company under the Securities Act and the rules and regulations of the Commission thereunder
and the Public Company Accounting Oversight Board (United States);



 


		(o)	The Company maintains a system of internal control over financial reporting (as such term is defined in
Rule 13a-15(f) under the Exchange Act) that complies with the requirements of the Exchange Act and has been designed by the Company’s
principal executive officer and principal financial officer, or under their supervision, to provide reasonable assurance (i) regarding
the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally
accepted accounting principles in the United States (“GAAP”) and the Commission’s rules and guidelines applicable thereto
and (ii) that the interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Pricing Disclosure
Package and the Offering Memorandum fairly presents the information called for in all material respects and is prepared in accordance
with the Commission’s rules and guidelines applicable thereto; and except as disclosed in the Pricing Disclosure Package, the Company’s
internal control over financial reporting is effective and the Company is not aware of any material weaknesses in its internal control
over financial reporting;



 






    5


     


    

 


		(p)	Since the date of the latest audited financial statements included in the Pricing Disclosure Package,
there has been no change in the Company’s internal control over financial reporting that has materially and adversely affected,
or is reasonably likely to materially and adversely affect, the Company’s internal control over financial reporting;



 


		(q)	The Company maintains disclosure controls and procedures (as such term is defined in Rule 13a-15(e) under
the Exchange Act) that comply with the requirements of the Exchange Act; such disclosure controls and procedures have been designed to
ensure that material information relating to the Company and its subsidiaries is made known to the Company’s principal executive
officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective;



 


		(r)	This Agreement has been duly authorized, executed and delivered by the Company and the Guarantor;



 


		(s)	The Indenture has been duly authorized by the Company and the Guarantor and, at the First Time of Delivery
(as defined in Section 4(a) hereof), will have been duly executed and delivered by the Company and the Guarantor and will constitute a
valid and binding agreement of the Company and the Guarantor, enforceable against the Company and the Guarantor in accordance with its
terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating to
fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except
as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in
equity or at law);



 


		(t)	The Notes have been duly authorized by the Company and, at the Time of Delivery of the Notes, will have
been duly executed by the Company and, when authenticated, issued and delivered in the manner provided for in the Indenture and delivered
against payment of the purchase price therefor as provided in this Agreement, will constitute valid and binding obligations of the Company,
enforceable against the Company in accordance with their terms, except as the enforcement thereof may be limited by bankruptcy, insolvency
(including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement
of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless of whether
enforcement is considered in a proceeding in equity or at law), and will be in the form contemplated by, and entitled to the benefits
of, the Indenture;



 


		(u)	The Guarantee has been duly authorized by the Guarantor and, when the Notes have been duly executed, authenticated,
issued and delivered in the manner provided for in the Indenture and delivered against payment of the purchase price therefor as provided
in this Agreement, will constitute valid and binding obligations of the Guarantor, enforceable against the Guarantor in accordance with
its terms, except as the enforcement thereof may be limited by bankruptcy, insolvency (including, without limitation, all laws relating
to fraudulent transfers), reorganization, moratorium or similar laws affecting enforcement of creditors’ rights generally and except
as enforcement thereof is subject to general principles of equity (regardless of whether enforcement is considered in a proceeding in
equity or at law), and will be in the form contemplated by, and entitled to the benefits of, the Indenture;



 


		(v)	The shares of Stock issuable upon conversion of the Securities have been duly authorized and reserved
for issuance upon such conversion by all necessary corporate action and such shares, when issued upon such conversion, will be validly
issued and will be fully paid and non-assessable; no holder of such shares will be subject to personal liability by reason of being such
a holder; and the issuance of such shares upon such conversion will not be subject to the preemptive or other similar rights of any securityholder
of the Company;



 






    6


     


    

 


		(w)	Neither the Company nor any of its subsidiaries or affiliates, nor any director, officer, or employee,
nor, to the Company’s or the Guarantor’s knowledge, any agent or representative of the Company or of any of its subsidiaries
or affiliates, has taken any action in furtherance of an offer, payment, promise to pay, or authorization or approval of the payment or
giving of money, property, gifts or anything else of value, directly or indirectly, to any “government official” (including
any officer or employee of a government or government-owned or controlled entity or of a public international organization, or any person
acting in an official capacity for or on behalf of any of the foregoing, or any political party or party official or candidate for political
office) to influence official action or secure an improper advantage; and the Company and its subsidiaries and affiliates have conducted
their businesses in compliance with applicable anti-corruption laws, including, without limitation, the U.S. Foreign Corrupt Practices
Act of 1977, and have instituted and maintained policies and procedures designed to promote and achieve compliance with such laws;



 


		(x)	The Company and its subsidiaries own or possess, or can acquire on commercially reasonable terms, adequate
rights to use all material patents, patent rights, licenses, inventions, copyrights, know how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names and other
intellectual property rights, moral rights and other rights (collectively, “Intellectual Property Rights”) used or employed
by them in connection with, or necessary for the conduct of, the business now operated by them;



 


		(y)	(A) There are no rights of third parties to any of the Intellectual Property Rights owned by the Company
or its subsidiaries (other than Intellectual Property Rights licensed or granted by the Company in the ordinary course of its business);
(B) there is no infringement, misappropriation, breach, default or other violation (1) by the Company or its subsidiaries of any of the
Intellectual Property Rights of third parties or (2) to the Company’ knowledge, by third parties of any of the Intellectual Property
Rights of the Company or its subsidiaries; and (C) there is no pending, or to the Company’s knowledge, threatened action, suit,
proceeding or claim by others (1) challenging the Company’s or any subsidiary’s rights in or to, or the validity, enforceability
or scope of, any of their Intellectual Property Rights, or (2) that the Company or any subsidiary infringes, misappropriates or otherwise
violates or conflicts with any Intellectual Property Rights of others, except in each case covered by clauses (A), (B) and (C) such as
would not, if determined adversely to the Company or any of its subsidiaries, individually or in the aggregate, reasonably be expected
to have a Material Adverse Effect;



 


		(z)	The financial statements, including the notes thereto, and the supporting schedules included in the Pricing
Disclosure Package present fairly, in all material respects, the financial position at the dates indicated and the results of operations
and cash flows for the periods indicated of the Company and its consolidated subsidiaries; except as otherwise stated in the Pricing Disclosure
Package, such financial statements have been prepared in conformity with GAAP applied on a consistent basis throughout the periods involved;
and the supporting schedules, if any, included in the Pricing Disclosure Package present fairly the information required to be stated
therein. The historical financial data set forth or included in the Pricing Disclosure Package under the captions “Offering Memorandum
Summary – Summary Consolidated Financial Data”, “Selected Financial Data” and “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” present fairly in all material respects the information included
therein. No other financial statements or supporting schedules would be required by the Securities Act to be included in a registration
statement on Form S-1 to be filed with the Commission if the offer and sale of the Securities contemplated hereunder were made pursuant
to such registration statement that have not been included in the Pricing Disclosure Package. The other financial information included
in the Pricing Disclosure Package presents fairly in all material respects the information included therein and has been prepared on a
basis consistent with that of the financial statements that are included in the Pricing Disclosure Package and the books and records of
the respective entities presented therein. The pro forma financial statements of the Company and its subsidiaries and the related notes
thereto incorporated by reference in the Pricing Disclosure Package present fairly the information contained therein, have been prepared
in accordance with the Commission’s rules and guidelines with respect to pro forma financial statements and have been properly presented
on the basis described therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are
appropriate to give effect to the transactions and circumstances referred to therein. The interactive data in eXtensible Business Reporting
Language included or incorporated by reference in the Pricing Disclosure Package and the Offering Memorandum fairly presents the information
called for in all material respects and has been prepared in accordance with the Commission’s rules and guidelines applicable thereto;



 






    7


     


    

 


		(aa)	The Company and each of its subsidiaries are insured by insurers of recognized financial responsibility
against such losses and risks and in such amounts as are, in the Company’s reasonable judgment, prudent and customary in the businesses
in which they are engaged; neither the Company nor any of its subsidiaries has been refused any insurance coverage sought or applied for;
and neither the Company nor any of its subsidiaries has any reason to believe that it will not be able to renew its existing insurance
coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business
at a cost that would not have a Material Adverse Effect;



 


		(bb)	The Company is in compliance in all material respects with all applicable provisions of the Sarbanes-Oxley
Act of 2002, as amended, and all rules and regulations promulgated thereunder currently in effect and with which the Company is required
to comply;



 


		(cc)	Except as described in the Pricing Disclosure Package, during the six-month period preceding the date
hereof, none of the Company, the Guarantor or any person acting on behalf of the Company or the Guarantor has offered, sold, issued or
distributed to any person any shares of Stock and any securities of the same or a similar class as the Securities, including any offers
and sales pursuant to Rule 144A under, or Regulation D or S of, the Securities Act, other than the Securities offered or sold to the Purchasers
hereunder or shares issued pursuant to employee benefit plans, qualified stock option plans or other employee compensation plans or pursuant
to outstanding options, rights or warrants; the Company and the Guarantor will take reasonable precautions designed to ensure that any
offer or sale, direct or indirect, in the United States or to any U.S. person (as defined in Rule 902 under the Securities Act) of any
Securities or any substantially similar security issued by the Company or the Guarantor, within six months subsequent to the date on which
the distribution of the Securities has been completed (as notified to the Company by Morgan Stanley & Co. LLC), is made under restrictions
and other circumstances reasonably designed not to affect the status of the offer and sale of the Securities in the United States and
to U.S. persons contemplated by this Agreement as transactions exempt from the registration provisions of the Securities Act;



 


		(dd)	There are no statutes, regulations, contracts or other documents that would be required by the Securities
Act to be described in a registration statement on Form S-1 to be filed with the Commission if the offer and sale of the Securities contemplated
hereunder were made pursuant to such registration statement that have not been described in each of the Pricing Disclosure Package and
the Offering Memorandum;



 


		(ee)	All United States federal tax returns and state tax returns required to be filed by the Company and its
subsidiaries in all jurisdictions in which the Company or its subsidiaries are incorporated or formed or are qualified to do business
have been timely and duly filed, or the Company and its subsidiaries have requested and received extensions thereof, other than those
filings being contested in good faith, and except where the failure to file would not have a Material Adverse Effect. Other than as disclosed
in the Pricing Disclosure Package, there are no tax returns of the Company and its subsidiaries that are currently being audited by state,
local or federal taxing authorities or agencies (and with respect to which the Company or its subsidiaries has received notice). All material
taxes, including withholding taxes, penalties and interest, assessments, fees and other charges due or claimed to be due to such entities
(and with respect to which the Company or its subsidiaries have received notice), have been paid, other than those being contested in
good faith and for which adequate reserves have been provided or those currently payable without penalty or interest;



 


		(ff)	The operations of the Company and its subsidiaries are and have been conducted at all times in material
compliance with the Employee Retirement Income Security Act of 1974, as amended, including the regulations and published interpretations
thereunder, and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively,
the “Employee Benefit Laws”) and no action, suit or proceeding by or before any court or governmental agency, authority or
body or any arbitrator to which the Company or any of its subsidiaries is a party with respect to the Employee Benefit Laws is pending
or, to the knowledge of the Company, threatened;



 






    8


     


    

 


		(gg)	No material labor dispute with the employees of the Company or any of its subsidiaries exists, except
as described in the Pricing Disclosure Package, or, to the knowledge of the Company, is imminent;



 


		(hh)	Except as disclosed in the Pricing Disclosure Package, there are no contracts, agreements or understandings
between the Company or its subsidiaries and any person that would give rise to a valid claim against the Company or any Purchaser for
a brokerage commission, finder’s fee or other like payment in connection with this offering;



 


		(ii)	None of the outstanding shares of Stock were issued in violation of any preemptive rights, rights of first
refusal or other similar rights to subscribe for or purchase securities of the Company; there are no persons with registration or other
similar rights to have securities of the Company registered under the Securities Act other than as disclosed in the Pricing Disclosure
Package; there are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase,
or equity or debt securities convertible into or exchangeable or exercisable for, any capital stock of the Company or any of its subsidiaries
other than those described in the Pricing Disclosure Package; and the description of the Company’s stock option, stock bonus and
other stock plans or arrangements, and the options or other rights granted thereunder, included in the Pricing Disclosure Package fairly
presents the information required to be shown with respect to such plans, arrangements, options and rights;



 


		(jj)	Prior to the date hereof, neither the Company nor any of its affiliates has taken any action which is
designed to or which has constituted or which might have been expected to cause or result in stabilization or manipulation of the price
of any security of the Company in connection with the offering of the Securities;



 


		(kk)	Neither the Company nor any person acting on its or their behalf (other than the Purchasers, as to which
no representation is made) has offered or sold the Securities by means of any general solicitation or general advertising within the meaning
of Rule 502(c) under the Securities Act or in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities
Act;



 


		(ll)	When issued, the Securities will not be of the same class (within the meaning of Rule 144A under the Securities
Act) as securities listed on a national securities exchange registered under Section 6 of the Exchange Act or quoted in a U.S. automated
inter-dealer quotation system;



 


		(mm)	Assuming the accuracy of the representations and warranties of the Purchasers contained in Section 3 and
their compliance with their agreements set forth therein, it is not necessary, in connection with the issuance and sale of the Securities
to the Purchasers and the offer, resale and delivery of the Securities by the Purchasers in the manner contemplated by this Agreement,
the Pricing Disclosure Package and the Offering Memorandum, to register the Securities under the Securities Act or to qualify the Indenture
under the Trust Indenture Act of 1939, as amended;



 


		(nn)	Neither the Company nor any of its subsidiaries, nor any director, officer, or employee thereof, nor,
to the Company’s or the Guarantor’s knowledge, any agent, affiliate or representative of the Company or any of its subsidiaries,
is an individual or entity (“Person”) that is, or is owned or controlled by a Person that is (A) the subject of any sanctions
administered or enforced by the U.S. Department of Treasury’s Office of Foreign Assets Control, the United Nations Security Council,
the European Union, Her Majesty’s Treasury, or other relevant sanctions authority (collectively, “Sanctions”) or (B)
located, organized or resident in a country or territory that is the subject of Sanctions (including, without limitation, the Crimea,
the so-called Donetsk People’s Republic and the so-called Luhansk People’s Republic regions of Ukraine, Cuba, Iran, North
Korea, Sudan and Syria); the Company will not, directly or indirectly, use the proceeds of the offering, or lend, contribute or otherwise
make available such proceeds to any subsidiary, joint venture partner or other Person (x) to fund or facilitate any activities or business
of or with any Person or in any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or
(y) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in the offering,
whether as Purchaser, advisor, investor or otherwise); and the Company and its subsidiaries have not knowingly engaged in, are not now
knowingly engaged in, and will not engage in, any dealings or transactions with any Person, or in any country or territory, that at the
time of the dealing or transaction is or was the subject of Sanctions;



 






    9


     


    

 


		(oo)	The operations of the Company and its subsidiaries are and have been conducted at all times in compliance
with applicable financial record-keeping and reporting requirements, including those of the Bank Secrecy Act, as amended by Title III
of the Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA
PATRIOT Act), the Currency and Foreign Transactions Reporting Act of 1970, as amended, the applicable money laundering statutes of jurisdictions
where the Company and the Subsidiaries conduct business, the applicable rules and regulations thereunder and any related or similar rules,
regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Money Laundering Laws”),
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened;



 


		(pp)	The Company and its subsidiaries possess all certificates, authorizations, registrations and permits issued
by the appropriate federal, state, self-regulatory organization or foreign regulatory authorities necessary to conduct their respective
businesses, except where the failure to possess any such certificate, authorization, registration or permit would not, individually or
in the aggregate, reasonably be expected to have a Material Adverse Effect; and neither the Company nor any of its subsidiaries has received
any notice of proceedings relating to the revocation or modification of any such certificate, authorization, registration or permit which,
individually or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would reasonably be expected to have a
Material Adverse Effect, except as described in the Pricing Disclosure Package;



 


		(qq)	Other than the Guarantor, Envestnet Portfolio Solutions, Inc., Envestnet Retirement Solutions, LLC, QRG
Capital Management, Inc., Envestnet Embedded Advisory, Inc. and FDx Advisors, Inc. (collectively, the “RIAs”), each of which
is registered with the Commission as an investment adviser, neither the Company nor any of its subsidiaries (A) is or has been registered
or (B) is required or has been required to be registered or (C) as a result of the transaction contemplated by this Agreement, will be
required to register, as an investment adviser under the Investment Advisers Act of 1940, as amended (the “IAA”), as a commodity
trading advisor, a commodity pool operator or a futures commission merchant under the Commodity Exchange Act of 1936, as amended, as a
broker or a dealer under the Exchange Act or under the Blue Sky or securities laws of any applicable jurisdiction or the rules and regulations
thereunder, except for such registration under the Blue Sky or securities laws of any applicable jurisdiction or the rules and regulations
thereunder the failure of which to have been complied with would not reasonably be expected to have a Material Adverse Effect;



 


		(rr)	Each of the RIAs (A) is duly registered as an investment adviser under the IAA and the rules, regulations
and interpretations of the Commission thereunder and has been duly registered from the time such registration has been required, and such
registration is, and has been from the time such registration was required, effective and in good standing, (B) is duly qualified as an
investment adviser under the securities laws and the rules and regulations thereunder of each jurisdiction in which the conduct of its
business requires such qualification, except to the extent that the failure to be so qualified would not reasonably be expected to have
a Material Adverse Effect; (C) has filed a Form ADV, including without limitation a firm brochure disclosing information required by Form
ADV Part 2A, with the Commission in accordance with the IAA, which Form at the time of filing was, as amended and supplemented as of the
date hereof is in effect pursuant to the requirements of the IAA and the rules, regulations and interpretations of the Commission thereunder
and accurate and complete in all material respects; (D) has prepared and delivered to clients, in compliance with the requirements of
Form ADV, one or more brochure supplements disclosing information required by Form ADV Part 2B, and has amended such brochure supplements,
and delivered such amended brochure supplements to clients from time to time in compliance with the requirements of the IAA and the rules
promulgated thereunder, and all such brochure supplements are accurate and complete as of the date hereof, and were accurate and complete
at the time of delivery to each client, in all material respects; (E) has (x) obtained all other necessary approvals, (y) made all filings,
including reports and other documents and (z) made all disclosures and delivered all documents to be delivered to its clients, as required
by the IAA and the rules, regulations and interpretations of the Commission thereunder and all applicable regulatory authorities to conduct
its business, except for where the failure to do so would not reasonably be expected to have a Material Adverse Effect; (F) has not received
any notification from any applicable regulatory authority to the effect that any additional approvals from such regulatory authority are
needed to be obtained by the RIA in any case where it could be reasonably expected that the RIA would in fact be required either to obtain
any such additional approvals or cease or otherwise limit engaging in certain business, except for such cessations or limitations of business
which would not reasonably be expected to have a Material Adverse Effect; (G) has maintained in all material respects all books and other
records required by the IAA and the rules, regulations and interpretations of the Commission thereunder, and, to the extent applicable,
the Investment Company Act and the rules promulgated thereunder, and each of such reports and other documents at the time created was,
as amended and supplemented as of the date hereof is, and after consummation of the transactions contemplated hereby shall be, accurate
and complete in all material respects; and (H) is in compliance in all material respects with the requirements of the IAA and the rules,
regulations and interpretations of the Commission thereunder and all other applicable investment adviser laws and regulations of each
jurisdiction which are applicable to such RIA, and has filed all notices required to be filed thereunder;



 






    10


     


    

 


		(ss)	Each investment advisory agreement to which any of the RIAs is a party is, and following the consummation
of the transactions contemplated by the Agreement will be, a valid and legally binding obligation of such RIA and is in compliance with
the applicable provisions of the IAA and the rules, regulations and interpretations of the Commission thereunder, and the applicable RIA
is not, and following the consummation of the transactions contemplated by the Agreement will not be, in breach or violation of or in
default under any such investment advisory agreement, except to the extent that any such noncompliance, breach, violation or default would
not, individually or in the aggregate, have a Material Adverse Effect;



 


		(tt)	Each entity for which any of the RIAs acts as investment adviser and, to the best knowledge of the RIAs,
each entity for which the RIAs acts as subadviser and, in each case, which is required to be registered with the Commission as an investment
company under the Investment Company Act (a “RIC”) is, and at the time of consummation of the transactions contemplated herein
will be, duly registered with the Commission as an investment company under the Investment Company Act and to the best knowledge of the
Company, each RIC has been operated in compliance in all material respects with the Investment Company Act and the rules and regulations
thereunder and to the best knowledge of the Company, there are no facts with respect to any such RIC that are likely to have a Material
Adverse Effect; and, to the best knowledge of the Company, each RIC’s registration statement complies in all material respects with
the provisions of the Securities Act, the Investment Company Act and the rules and regulations thereunder and does not contain any untrue
statement of material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein
not misleading;



 


		(uu)	The Company and its subsidiaries’ information technology assets and equipment, computers, systems,
networks, hardware, software, websites, applications, and databases (collectively, “IT Systems”) are adequate for, and operate
and perform in all material respects as required in connection with the operation of the business of the Company and its subsidiaries
as currently conducted, and are, to the knowledge of the Company, free and clear of all material bugs, errors, defects, Trojan horses,
time bombs, malware and other corruptants. The Company and its subsidiaries have implemented and maintained commercially reasonable controls,
policies, procedures, and safeguards to maintain and protect their material confidential information and the integrity, continuous operation,
redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated
data (“Personal Data”)) used in connection with their businesses, and there have been no breaches, violations, outages or
unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify
any other person, nor, to the knowledge of the Company, any investigations relating to the same. The Company and its subsidiaries are
presently in material compliance with all applicable laws or statutes and all judgments, orders, rules and regulations of any court or
arbitrator or governmental or regulatory authority, internal policies and contractual obligations relating to the privacy and security
of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation
or modification; and



 


		(vv)	Each of the Base Capped Call Confirmations has been, and each Additional Capped Call Confirmation on the
date of its execution will have been, duly authorized, executed and delivered by the Company and, assuming due execution and delivery
thereof by the Option Counterparties, constitutes, or will constitute, as the case may be, a valid and legally binding agreement of the
Company enforceable against the Company in accordance with its terms, except as the enforcement thereof may be limited by bankruptcy,
insolvency (including, without limitation, all laws relating to fraudulent transfers), reorganization, moratorium or similar laws affecting
enforcement of creditors’ rights generally and except as enforcement thereof is subject to general principles of equity (regardless
of whether enforcement is considered in a proceeding in equity or at law).



 






    11


     


    

 


	2.	(a)	Subject to the terms and conditions herein set
forth, (i) the Company agrees to issue and sell to each of the Purchasers, and each of the Purchasers agrees, severally and not jointly,
to purchase from the Company, at a purchase price of 97.250% of the principal amount thereof plus accrued interest, if any, from November
17, 2022 to the First Time of Delivery, the principal amount of Firm Notes set forth opposite the name of such Purchaser in Schedule
I and (ii) in the event and to the extent that the Purchasers shall exercise the election to purchase Optional Notes as provided in Section
2(b) below, the Company agrees to issue and sell to each of the Purchasers, and each of the Purchasers agrees, severally and not jointly,
to purchase from the Company, at a purchase price of 97.250% of the principal amount thereof plus accrued interest, if any, from November
17, 2022 to the applicable Time of Delivery, that portion of the number of Optional Notes as to which such election shall have been exercised.





 


		(b)	The Company hereby grants to the Purchasers the right to purchase at their election up to $75,000,000
aggregate principal amount of Optional Notes, at the purchase price set forth in Section 2(a)(ii). Any such election to purchase Optional
Notes may be exercised in whole or from time to time in part by written notice from you to the Company setting forth the aggregate principal
amount of Optional Notes to be purchased and the date on which such Optional Notes are to be delivered, as determined by you but in no
event later than the thirteenth day from and including the First Time of Delivery or earlier than the First Time of Delivery or, unless
you and the Company otherwise agree in writing, earlier than two business days after the date of such notice. Optional Notes may be purchased
as provided in this Section 2(b) hereof solely for the purpose of covering overallotments made in connection with the offering of the
Firm Notes.



 


		3.	Upon the authorization by you of the release of the Securities, the several Purchasers propose to offer
the Securities for sale upon the terms and conditions set forth in this Agreement and the Offering Memorandum and each Purchaser, acting
severally and not jointly, hereby represents and warrants to, and agrees with the Company and the Guarantor that:



 


		(a)	It will sell the Securities only to persons who it reasonably believes are “qualified institutional
buyers” (“QIBs”) within the meaning of Rule 144A under the Securities Act in transactions meeting the requirements of
Rule 144A;



 


		(b)	It will not make any general solicitation or general advertising within the meaning of Rule 502(c) under
the Securities Act or solicit offers for, or offer or sell, the Securities in any manner involving a public offering within the meaning
of Section 4(a)(2) of the Securities Act; and



 


		(c)	It is an institutional “accredited Investor” (“Institutional Accredited Investor”)
within the meaning of Rule 501 under the Securities Act.



 


	4.	(a)	The Notes to be purchased by each Purchaser hereunder
will be represented by one or more definitive global Notes in book-entry form which will be deposited by or on behalf of the Company
with The Depository Trust Company (“DTC”) or its designated custodian. The Company will deliver the Notes to Morgan Stanley
& Co. LLC, for the account of each Purchaser, against payment by or on behalf of such Purchaser of the purchase price therefor by
wire transfer in Federal (same day) funds, by causing DTC to credit the Notes to the account of Morgan Stanley & Co. LLC at DTC.
The Company will cause the definitive global Notes to be made available to the Representatives for checking at least twenty-four hours
prior to the Time of Delivery (as defined below) at the office of Sidley Austin LLP, 787 7th Avenue, New York, New York, 10019 (the “Closing
Location”) The time and date of such delivery and payment shall be, with respect to the Firm Notes, 9:30 a.m., New York City time,
on November 17, 2022, or at such other time and date as the Representatives and the Company may agree upon in writing and, with respect
to the Optional Notes, 9:30 a.m., New York City time, on the date specified by you in the written notice given by you of the Purchasers’
election to purchase the Optional Notes, or at such other time and date as the Representatives and the Company may agree upon in writing.
Such time and date of delivery of the Firm Notes is herein called the “First Time of Delivery,” such time and date for delivery
of the Optional Notes, if not the First Time of Delivery, is herein called an “Additional Time of Delivery,” and each such
time and date of delivery is herein called a “Time of Delivery”.





 






    12


     


    

 


		(b)	The documents to be delivered at each Time of Delivery by or on behalf of the parties hereto pursuant
to Section 8 hereof, including the cross-receipt for the Securities and any additional documents requested by the Purchasers pursuant
to Section 8(l) hereof, will be delivered at such Time of Delivery at the Closing Location, and the Securities will be delivered through
DTC, all at such Time of Delivery. A meeting will be held at the Closing Location at 3:00 p.m., New York City time, on the New York Business
Day next preceding such Time of Delivery, at which meeting the final drafts of the documents to be delivered pursuant to the preceding
sentence will be available for review by the parties hereto. For the purposes of this Section 4, “New York Business Day” shall
mean each Monday, Tuesday, Wednesday, Thursday and Friday which is not a day on which banking institutions in New York are generally authorized
or obligated by law or executive order to close.



 


		5.	The Company and the Guarantor, jointly and severally, agree with each of the Purchasers:



 


		(a)	To prepare the Offering Memorandum in a form approved by you; to make no amendment or any supplement to
the Offering Memorandum to which you reasonably object after reasonable notice thereof; and to furnish you with copies thereof;



 


		(b)	Promptly from time to time to take such action as you may reasonably request to qualify the Securities
for offering and sale under the securities laws of such jurisdictions as you may request and to comply with such laws so as to permit
the continuance of sales and dealings therein in such jurisdictions for as long as may be necessary to complete the distribution of the
Securities, provided that in connection therewith the Company shall not be required to qualify as a foreign corporation or to file a general
consent to service of process in any jurisdiction or subject itself to taxation in any jurisdiction in which it is not otherwise subject
to taxation on the date hereof;



 


		(c)	To furnish the Purchasers with written and electronic copies of the Offering Memorandum and any amendment
or supplement thereto in such quantities as you may from time to time reasonably request, and if, during such period after the date hereof
and prior to the date on which all of the Notes shall have been sold by the Purchasers, any event shall have occurred as a result of which
the Offering Memorandum as then amended or supplemented would include an untrue statement of a material fact or omit to state any material
fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when the Offering
Memorandum is delivered, not misleading, or, if, in the reasonable opinion of counsel for the Purchasers, for any other reason it shall
be necessary during such same period to amend or supplement the Offering Memorandum in order to comply with applicable law, to notify
you and upon your request to prepare and furnish without charge to each Purchaser and to any dealer in securities as many written and
electronic copies as you may from time to time reasonably request of an amended Offering Memorandum or a supplement to the Offering Memorandum
which will correct such statement or omission or effect such compliance;



 


		(d)	During the period commencing on the date hereof and continuing to and including the date 60 days after
the date of the Offering Memorandum, not to (1) offer, issue, pledge, sell, contract to sell, sell any option or contract to purchase,
purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, pledge, hypothecate or otherwise transfer
or dispose of, directly or indirectly, any shares of Stock beneficially owned (as such term is used in Rule 13d-3 under the Exchange Act)
or any other securities so owned convertible into or exercisable or exchangeable for Stock or (2) enter into any swap, hedge or other
arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of the Stock or such other securities,
whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Stock or such other securities, in cash
or otherwise or (3) file or confidentially submit any registration statement with the Commission relating to the offering of any shares
of Stock or any securities convertible into or exercisable or exchangeable for Stock, without the prior written consent of you on behalf
of the Purchasers (other than (a) the grant of options to purchase shares of Stock, restricted shares or restricted stock units pursuant
to the Company’s existing employee benefit plans or the issuance of shares of Stock upon the exercise of any option issued pursuant
to the Company’s employee benefit plans (or the filing of a registration statement on Form S-8 to register shares of Stock issuable
under such plans), (b) the issuance by the Company of shares of Stock upon the exercise of a warrant or the conversion of a security outstanding
on the date hereof, (c) the issuance by the Company of shares of Stock in an amount up to 10% of the Company’s outstanding shares
of Stock in connection with a merger, acquisition or other transaction, provided that any individual or entity receiving shares of Stock
pursuant to this clause (c) shall enter into a written agreement, satisfactory to the Representatives and in all material respects consistent
with the terms of the agreement set forth in Annex III, (d) the issuance by the Company of shares of Stock pursuant to any pre-existing
contractual obligation of the Company identified in the Offering Memorandum and (e) the Company’s entry into or termination of,
and its exercise of rights and performance of obligations under, the Capped Call Confirmations);



 






    13


     


    

 


		(e)	At any time when the Company is not subject to Section 13 or 15(d) of the Exchange Act, for the benefit
of holders from time to time of Securities, to furnish at its expense, upon request, to holders of Securities and prospective purchasers
of Securities information (the “Additional Issuer Information”) satisfying the requirements of subsection (d)(4)(i) of Rule
144A under the Securities Act;



 


		(f)	During the period of three years after the last Time of Delivery hereunder, to furnish to the holders
of the Securities as soon as practicable after the end of each fiscal year an annual report (including a balance sheet and statements
of income, stockholders' equity and cash flows of the Company and its consolidated subsidiaries certified by independent public accountants)
and, as soon as practicable after the end of each of the first three quarters of each fiscal year (beginning with the fiscal quarter ending
after the date of the Offering Memorandum), to make available to its stockholders consolidated summary financial information of the Company
and its subsidiaries for such quarter in reasonable detail; provided, however, that the Company may satisfy the requirements of
this subsection by making such reports or information available on its website or by electronically filing such information through EDGAR
as long as such posting or filing complies with the Exchange Act;



 


		(g)	During the period of one year after the last Time of Delivery hereunder, the Company will not, and will
not permit any of its “affiliates” (as defined in Rule 144 under the Securities Act) to, resell any of the Securities which
constitute “restricted securities” under Rule 144 that have been reacquired by any of them (other than pursuant to a registration
statement that has been declared effective under the Securities Act);



 


		(h)	To use the net proceeds received by the Company from the sale of the Securities pursuant to this Agreement
in the manner specified in the Preliminary Offering Memorandum and the Offering Memorandum under the caption “Use of Proceeds;”



 


		(i)	To reserve and keep available at all times, free of preemptive rights, shares of Stock for the purpose
of enabling the Company to satisfy any obligations to issue shares of its Stock upon conversion of the Securities; and



 


		(j)	To use its commercially reasonable efforts to list, subject to notice of issuance, the shares of Stock
issuable upon conversion of the Securities on the New York Stock Exchange (the “NYSE”).



 


	6.	(a)	Each of the Company and the Guarantor represents
and agrees that, without the prior consent of the Representatives, it and its affiliates and any other person acting on its or their
behalf (other than the Purchasers, as to which no statement is given) (x) have not made and will not make any offer relating to the Securities
that, if the offering of the Securities contemplated by this Agreement were conducted as a public offering pursuant to a registration
statement filed under the Securities Act with the Commission, would constitute an “issuer free writing prospectus,” as defined
in Rule 433 under the Securities Act (any such offer is hereinafter referred to as a “Company Supplemental Disclosure Document”)
and (y) have not solicited and will not solicit offers for, and have not offered or sold and will not offer or sell, the Securities by
means of any form of general solicitation or general advertising within the meaning of Rule 502(c) of Regulation D or in any manner involving
a public offering within the meaning of Section 4(a)(2) of the Securities Act.





 


		(b)	Each Purchaser, severally and not jointly, represents and agrees that, without the prior consent of the
Company and the Representatives, other than one or more term sheets relating to the Securities containing customary information and conveyed
to purchasers of securities, it has not made and will not make any offer relating to the Securities that, if the offering of the Securities
contemplated by this Agreement were conducted as a public offering pursuant to a registration statement filed under the Securities Act
with the Commission, would constitute a “free writing prospectus,” as defined in Rule 405 under the Securities Act (any such
offer (other than any such term sheets), is hereinafter referred to as a “Purchaser Supplemental Disclosure Document”).



 


		(c)	Any Company Supplemental Disclosure Document or Purchaser Supplemental Disclosure Document, the use of
which has been consented to by the Company and the Representatives, is listed, as applicable, on Schedule II(a) or Schedule II(b) hereto,
respectively.



 






    14


     


    

 


		7.	The Company and the Guarantor, jointly and severally, covenant and agree with the several Purchasers that
the Company and the Guarantor will pay or cause to be paid the following: (i) the fees, disbursements and expenses of the Company’s
and the Guarantor’s counsel and accountants in connection with the issue of the Securities and the shares of Stock issuable upon
conversion of the Securities and all other expenses in connection with the preparation, printing, reproduction and filing of the Preliminary
Offering Memorandum and the Offering Memorandum and any amendments and supplements thereto and the mailing and delivering of copies thereof
to the Purchasers and dealers; (ii) the cost of printing or producing any Agreement among Purchasers, this Agreement, the Indenture, the
Securities, any Blue Sky memorandum, closing documents (including any compilations thereof) and any other documents in connection with
the offering, purchase, sale and delivery of the Securities; (iii) all expenses in connection with the qualification of the Securities
and the shares of Stock issuable upon conversion of the Securities for offering and sale under state securities laws as provided in Section
5(b) hereof, including the fees (not to exceed $5,000) and disbursements of counsel for the Purchasers in connection with such qualification
and in connection with Blue Sky surveys; (iv) any fees charged by securities rating services for rating the Securities; (v) the cost of
preparing the Securities; (vi) the fees and expenses of the Trustee and any agent of the Trustee and the fees and disbursements of counsel
for the Trustee in connection with the Indenture and the Securities; (vii) all costs and expenses incurred in connection with any “road
show” presentation to potential purchasers of the Securities; and (viii) any cost incurred in connection with the listing of the
shares of Stock issuable upon conversion of the Securities; and all other costs and expenses incident to the performance of its obligations
hereunder which are not otherwise specifically provided for in this Section. It is understood, however, that, except as provided in this
Section, and Sections 9 and 12 hereof, the Purchasers will pay all of their own costs and expenses, including the fees of their counsel,
transfer taxes on resale of any of the Securities by them, and any advertising expenses connected with any offers they may make.



 


		8.	The obligations of the Purchasers hereunder, as to the Notes to be delivered at each Time of Delivery,
shall be subject, in their discretion, to the condition that all representations and warranties and other statements of the Company and
the Guarantor herein are, at and as of such Time of Delivery, true and correct, the condition that the Company and the Guarantor shall
have performed all of their respective obligations hereunder theretofore to be performed, and the following additional conditions:



 


		(a)	Sidley Austin LLP, counsel for the Purchasers, shall have furnished
to you such written opinion or opinions, dated such Time of Delivery, in form and substance satisfactory to you, with respect to the matters
you may reasonably request, and such counsel shall have received such papers and information as they may reasonably request to enable
them to pass upon such matters;



 


		(b)	Mayer Brown LLP, counsel for the Company and the Guarantor, shall have furnished to you their written
opinion, dated such Time of Delivery, in the form attached hereto as Annex I;



 


		(c)	Shelly O’Brien, the Chief Legal Officer and General Counsel of the Company, shall have furnished
to you her written opinion, dated such Time of Delivery, in the form attached hereto as Annex II;



 


		(d)	On the date of the Offering Memorandum concurrently with the execution of this Agreement and also at each
Time of Delivery, KPMG LLP, independent certified public accountants with respect to the Company, shall have furnished to you a letter
or letters with respect to the Company, dated the respective dates of delivery thereof, in form and substance satisfactory to you;



 


		(e)	On the date of the Offering Memorandum concurrently with the execution of this Agreement and also at each
Time of Delivery, the Chief Financial Officer of the Company shall have furnished to you a certificate executed by the Chief Financial
Officer, dated the respective dates of delivery thereof, in form and substance satisfactory to you, covering certain financial and operating
information of the Company included or incorporated by reference in the Pricing Disclosure Package and the Offering Memorandum;



 






    15


     


    

 


		(f)	(i) Neither the Company nor any of its subsidiaries shall have sustained since the date of the latest
audited financial statements included or incorporated by reference in the Pricing Disclosure Package any loss or interference with its
business from fire, explosion, flood or other calamity, whether or not covered by insurance, or from any labor dispute or court or governmental
action, order or decree, otherwise than as set forth or contemplated in the Pricing Disclosure Package, and (ii) since the respective
dates as of which information is given in the Pricing Disclosure Package there shall not have been any change in the capital stock, short-term
debt or long-term debt of the Company or any of its subsidiaries or any change, or any development involving a prospective change, in
or affecting the general affairs, management, financial position, stockholders’ equity or results of operations of the Company and
its subsidiaries, otherwise than as set forth or contemplated in the Pricing Disclosure Package, the effect of which, in any such case
described in clause (i) or (ii), is in your judgment so material and adverse as to make it impracticable or inadvisable to proceed with
the offering or the delivery of the Securities being issued at such Time of Delivery on the terms and in the manner contemplated in this
Agreement and in each of the Pricing Disclosure Package and the Offering Memorandum;



 


		(g)	On or after the Applicable Time (i) no downgrading shall have occurred in the rating accorded the Company’s
debt securities by any “nationally recognized statistical rating organization”, as that term is defined by the Commission
for purposes of Rule 436(g)(2) under the Securities Act, and (ii) no such organization shall have publicly announced that it has under
surveillance or review, with possible negative implications, its rating of any of the Company’s debt securities;



 


		(h)	On or after the Applicable Time there shall not have occurred any of the following: (i) a suspension or
material limitation in trading in securities generally on the NYSE or NASDAQ; (ii) a suspension or material limitation in trading in the
Company’s securities on the NYSE; (iii) a general moratorium on commercial banking activities declared by either Federal or New
York State authorities or a material disruption in commercial banking or securities settlement or clearance services in the United States;
(iv) the outbreak or escalation of hostilities involving the United States or the declaration by the United States of a national emergency
or war or (v) the occurrence of any other calamity or crisis or any change in financial, political or economic conditions in the United
States or elsewhere, if the effect of any such event specified in clause (iv) or (v) in your judgment makes it impracticable or inadvisable
to proceed with the offering or the delivery of the Securities being issued at such Time of Delivery on the terms and in the manner contemplated
in the Pricing Disclosure Package and the Offering Memorandum;



 


		(i)	The shares of Stock issuable upon conversion of the Securities shall have been approved for listing, subject
to notice of issuance, on the NYSE;



 


		(j)	The Company shall have obtained and delivered to the Purchasers executed copies of a lock-up agreement
from each of the persons listed on Schedule IV hereto, substantially in the form attached hereto as Annex III and such agreements shall
be in full force and effect.



 


		(k)	The Purchasers shall have received an executed copy of the Indenture;



 


		(l)	The Securities shall be eligible for clearance and settlement through the facilities of DTC; and



 


		(m)	The Company and the Guarantor shall have furnished or caused to be furnished to you at such Time of Delivery
certificates of officers of the Company and the Guarantor reasonably satisfactory to you as to the accuracy of the representations and
warranties of the Company and the Guarantor herein at and as of such Time of Delivery, as to the performance by the Company and the Guarantor
of all of their respective obligations hereunder to be performed at or prior to such Time of Delivery and as to such other matters as
you may reasonably request, and the Company shall have furnished or caused to be furnished certificates as to the matters set forth in
subsection (f)(i) of this Section 8 and as to the absence, since the respective dates as of which information is given in the Pricing
Disclosure Package, of any material adverse change in the capital stock, short-term debt or long-term debt of the Company or any of its
subsidiaries or any material adverse change, or any development involving a prospective material adverse change, in or affecting the general
affairs, management, financial position, stockholders’ equity or results of operations of the Company and its subsidiaries, otherwise
than as set forth or contemplated in the Pricing Disclosure Package.



 






    16


     


    

 


	9.	(a)	The Company and the Guarantor, jointly and severally,
will indemnify and hold harmless each Purchaser against any losses, claims, damages or liabilities, joint or several, to which such Purchaser
may become subject, under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect
thereof) arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in the Preliminary
Offering Memorandum, the Pricing Disclosure Package, the Offering Memorandum, or any amendment or supplement thereto, or any Company
Supplemental Disclosure Document or arise out of or are based upon the omission or alleged omission to state therein a material fact
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, and will reimburse
each Purchaser for any legal or other expenses reasonably incurred by such Purchaser in connection with investigating or defending any
such action or claim as such expenses are incurred; provided, however, that the Company and the Guarantor shall not be
liable in any such case to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement
or alleged untrue statement or omission or alleged omission made in the Preliminary Offering Memorandum, the Pricing Disclosure Package,
the Offering Memorandum or any such amendment or supplement or any Company Supplemental Disclosure Document, in reliance upon and in
conformity with written information furnished to the Company by any Purchaser through the Representatives expressly for use therein,
it being understood that the only information furnished to the Company for such use is the information contained in the first, second,
fifth, six, seventh and eighth sentence of the eighth paragraph and in the second sentence of the ninth paragraph under the caption “Plan
of Distribution” in the Preliminary Offering Memorandum and the Offering Memorandum (the “Purchasers’ Information”).





 


		(b)	Each Purchaser, severally and not jointly, will indemnify and hold harmless the Company and the Guarantor
against any losses, claims, damages or liabilities to which the Company and the Guarantor may become subject, under the Securities Act
or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon an
untrue statement or alleged untrue statement of a material fact contained in the Preliminary Offering Memorandum, the Pricing Disclosure
Package, the Offering Memorandum, or any amendment or supplement thereto, or any Company Supplemental Disclosure Document or arise out
of or are based upon the omission or alleged omission to state therein a material fact or necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading, in each case to the extent, but only to the extent, that such
untrue statement or alleged untrue statement or omission or alleged omission was made in the Preliminary Offering Memorandum, the Pricing
Disclosure Package, the Offering Memorandum or any such amendment or supplement, or any Company Supplemental Disclosure Document, in reliance
upon and in conformity with the Purchasers’ Information; and each Purchaser will reimburse the Company and the Guarantor for any
legal or other expenses reasonably incurred by the Company and the Guarantor in connection with investigating or defending any such action
or claim as such expenses are incurred.



 


		(c)	Promptly after receipt by an indemnified party under subsection (a) or (b) above of notice of the commencement
of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party under such subsection,
notify the indemnifying party in writing of the commencement thereof; but the omission so to notify the indemnifying party shall not relieve
it from any liability which it may have to any indemnified party otherwise than under such subsection. In case any such action shall be
brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall
be entitled to participate therein and, to the extent that it shall wish, jointly with any other indemnifying party similarly notified,
to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party (who shall not, except with the consent
of the indemnified party, be counsel to the indemnifying party), and, after notice from the indemnifying party to such indemnified party
of its election so to assume the defense thereof, the indemnifying party shall not be liable to such indemnified party under such subsection
for any legal expenses of other counsel or any other expenses, in each case, subsequently incurred by such indemnified party in connection
with the defense thereof, other than reasonable costs of investigation. No indemnifying party shall, without the written consent of the
indemnified party, effect the settlement or compromise of, or consent to the entry of any judgment with respect to, any pending or threatened
action or claim in respect of which indemnification or contribution may be sought hereunder (whether or not the indemnified party is an
actual or potential party to such action or claim) unless such settlement, compromise or judgment (i) includes an unconditional release
of the indemnified party from all liability arising out of such action or claim and (ii) does not include a statement as to, or an admission
of, fault, culpability or a failure to act, by or on behalf of any indemnified party.



 






    17


     


    

 


		(d)	If the indemnification provided for in this Section 9 is unavailable to or insufficient to hold harmless
an indemnified party under subsection (a) or (b) above in respect of any losses, claims, damages or liabilities (or actions in respect
thereof) referred to therein, then each indemnifying party shall contribute to the amount paid or payable by such indemnified party as
a result of such losses, claims, damages or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect
the relative benefits received by the Company and the Guarantor on the one hand and the Purchasers on the other from the offering of the
Securities. If, however, the allocation provided by the immediately preceding sentence is not permitted by applicable law or if the indemnified
party failed to give the notice required under subsection (c) above, then each indemnifying party shall contribute to such amount paid
or payable by such indemnified party in such proportion as is appropriate to reflect not only such relative benefits but also the relative
fault of the Company and the Guarantor on the one hand and the Purchasers on the other in connection with the statements or omissions
which resulted in such losses, claims, damages or liabilities (or actions in respect thereof), as well as any other relevant equitable
considerations. The relative benefits received by the Company and the Guarantor on the one hand and the Purchasers on the other shall
be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company
bear to the total discounts and commissions received by the Purchasers, as provided in this Agreement. The relative fault shall be determined
by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission
to state a material fact relates to information supplied by the Company and the Guarantor on the one hand or the Purchasers on the other
and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.
The Company, the Guarantor and the Purchasers agree that it would not be just and equitable if contribution pursuant to this subsection
(d) were determined by pro rata allocation (even if the Purchasers were treated as one entity for such purpose) or by any other method
of allocation which does not take account of the equitable considerations referred to above in this subsection (d). The amount paid or
payable by an indemnified party as a result of the losses, claims, damages or liabilities (or actions in respect thereof) referred to
above in this subsection (d) shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in connection
with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (d), no Purchaser shall be
required to contribute any amount in excess of the amount by which the total price at which the Securities purchased by it and distributed
to investors were offered to investors exceeds the amount of any damages which such Purchaser has otherwise been required to pay by reason
of such untrue or alleged untrue statement or omission or alleged omission. No person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation. The Purchasers’ obligations in this subsection (d) to contribute are several in proportion to their respective
purchase obligations and not joint.



 


		(e)	The obligations of the Company and the Guarantor under this Section 9 shall be in addition to any liability
which the Company and the Guarantor may otherwise have and shall extend, upon the same terms and conditions, to each employee, officer
and director of each Purchaser, any affiliate of each Purchaser, each employee, officer, director, partner and member of such affiliate
and each person, if any, who controls any Purchaser or such affiliate within the meaning of the Securities Act; and the obligations of
the Purchasers under this Section 9 shall be in addition to any liability which the respective Purchasers may otherwise have and shall
extend, upon the same terms and conditions, to each officer and director of the Company and the Guarantor and to each person, if any,
who controls the Company and the Guarantor within the meaning of the Securities Act.



 


	10.	(a)	If any Purchaser shall default in its obligation
to purchase the Notes which it has agreed to purchase hereunder at a Time of Delivery, you may in your discretion arrange for you or
another party or other parties to purchase such Notes on the terms contained herein. If within thirty-six hours after such default by
any Purchaser you do not arrange for the purchase of such Notes, then the Company shall be entitled to a further period of thirty-six
hours within which to procure another party or other parties satisfactory to you to purchase such Notes on such terms. In the event that,
within the respective prescribed periods, you notify the Company that you have so arranged for the purchase of such Notes, or the Company
notifies you that it has so arranged for the purchase of such Notes, you or the Company shall have the right to postpone such Time of
Delivery for a period of not more than seven days, in order to effect whatever changes may thereby be made necessary in the Offering
Memorandum, or in any other documents or arrangements, and the Company agrees to prepare promptly any amendments or supplements to the
Offering Memorandum which in your opinion may thereby be made necessary. The term “Purchaser” as used in this Agreement shall
include any person substituted under this Section with like effect as if such person had originally been a party to this Agreement with
respect to such Notes.





 






    18


     


    

 


		(b)	If, after giving effect to any arrangements for the purchase of the Notes of a defaulting Purchaser or
Purchasers by you and the Company as provided in subsection (a) above, the aggregate principal amount of such Notes which remains unpurchased
does not exceed one-eleventh of the aggregate principal amount of all the Notes to be purchased at such Time of Delivery, then the Company
shall have the right to require each non-defaulting Purchaser to purchase the aggregate principal amount of Notes which such Purchaser
agreed to purchase hereunder at such Time of Delivery and, in addition, to require each non-defaulting Purchaser to purchase its pro rata
share (based on the aggregate principal amount of Notes which such Purchaser agreed to purchase hereunder) of the Notes of such defaulting
Purchaser or Purchasers for which such arrangements have not been made; but nothing herein shall relieve a defaulting Purchaser from liability
for its default.



 


		(c)	If, after giving effect to any arrangements for the purchase of the Notes of a defaulting Purchaser or
Purchasers by you and the Company as provided in subsection (a) above, the aggregate principal amount of such Notes which remains unpurchased
exceeds one-eleventh of the aggregate principal amount of all the Notes to be purchased at such Time of Delivery, or if the Company shall
not exercise the right described in subsection (b) above to require non-defaulting Purchasers to purchase Notes of a defaulting Purchaser
or Purchasers, then this Agreement (or, with respect to an Additional Time of Delivery, the obligations of the Purchasers to purchase
and of the Company to sell the Optional Notes) shall thereupon terminate, without liability on the part of any non-defaulting Purchaser
or the Company, except for the expenses to be borne by the Company and the Purchasers as provided in Section 7 hereof and the indemnity
and contribution agreements in Section 9 hereof; but nothing herein shall relieve a defaulting Purchaser from liability for its default.



 


		11.	The respective indemnities, agreements, representations, warranties and other statements of the Company,
the Guarantor and the several Purchasers, as set forth in this Agreement or made by or on behalf of them, respectively, pursuant to this
Agreement, shall remain in full force and effect, regardless of any investigation (or any statement as to the results thereof) made by
or on behalf of any Purchaser or any controlling person of any Purchaser, or the Company, the Guarantor or any officer or director or
controlling person of the Company and the Guarantor, and shall survive delivery of and payment for the Notes.



 


		12.	If this Agreement shall be terminated pursuant to Section 10 hereof, the Company and the Guarantor shall
not then be under any liability to any Purchaser except as provided in Sections 7 and 9 hereof; but, if for any other reason (other than
the failure of the condition set forth in Section 8(h)(i), (iii), (iv) or (v)), any Notes are not delivered by or on behalf of the Company
as provided herein, the Company and the Guarantor will reimburse the Purchasers through you for all out-of-pocket expenses approved in
writing by you, including fees and disbursements of counsel, reasonably incurred by the Purchasers in making preparations for the purchase,
sale and delivery of the Notes, but the Company and the Guarantor shall then be under no further liability to any Purchaser except as
provided in Sections 7 and 9 hereof.



 


		13.	In all dealings hereunder, you shall act on behalf of each of the Purchasers, and the parties hereto shall
be entitled to act and rely upon any statement, request, notice or agreement on behalf of any Purchaser made or given by you jointly,
and any action under this Agreement taken by the Representatives jointly will be binding upon all the Purchasers.



 


All statements, requests, notices and
agreements hereunder shall be in writing, and if to the Purchasers shall be delivered or sent by mail or facsimile transmission to you
as the Representatives in care of: Morgan Stanley & Co. LLC, 1585 Broadway, New York, New York 10036, Attention Convertible Debt Syndicate
Desk, with a copy to the Legal Department; BofA Securities, Inc., One Bryant Park, New York, New York 10036, Attention: Syndicate Department
(fax: (646) 855-3073), with a copy to ECM Legal (fax: (212) 230-8730); BMO Capital Markets Corp., Attention: Equity Syndicate Department,
151 W. 42nd Street, 32nd Floor, New York, NY 10036, by email at bmoprospectus@bmo.com, or by phone at (800) 414-3627; and J.P. Morgan
Securities LLC, 383 Madison Avenue, New York, New York 10179, Attention: Equity Syndicate Desk, Telecopy No. 212-622-8358; and if to the
Company shall be delivered or sent by mail or facsimile transmission to Envestnet, Inc., 35 East Wacker Drive, Suite 2400, Chicago, Illinois
60601, Attention: Secretary, facsimile: (312) 827-2801; and if to any officer or director of the Company that has delivered a lock-up
agreement described in Section 8(j) hereof, shall be delivered or sent by mail to his or her address provided in Schedule IV hereto or
such other address as such officer or director provides in writing to the Company. Any such statements, requests, notices or agreements
shall take effect upon receipt thereof.


 


In accordance with the requirements
of the USA Patriot Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)), the Purchasers are required to obtain, verify
and record information that identifies their respective clients, including the Company and the Guarantor, which information may include
the name and address of their respective clients, as well as other information that will allow the Purchasers to properly identify their
respective clients.


 






    19


     


    

 


		14.	This Agreement shall be binding upon, and inure solely to the benefit of, the Purchasers, the Company,
the Guarantor and, to the extent provided in Sections 9 and 11 hereof, the officers and directors of the Company, the officers and directors
of the Guarantor, the employees, officers and directors of each Purchaser, any affiliate of each Purchaser, each employee, officer, director,
partner and member of such affiliate and each person who controls the Company, the Guarantor, any Purchaser or such affiliate, and their
respective heirs, executors, administrators, successors and assigns, and no other person shall acquire or have any right under or by virtue
of this Agreement. No purchaser of any of the Securities from any Purchaser shall be deemed a successor or assign by reason merely of
such purchase.



 


		15.	Time shall be of the essence of this Agreement.



 


		16.	The Company and the Guarantor acknowledge and agree that (i) the purchase and sale of the Notes pursuant
to this Agreement is an arm’s-length commercial transaction between the Company and the Guarantor, on the one hand, and the several
Purchasers, on the other, (ii) in connection therewith and with the process leading to such transaction each Purchaser is acting solely
as a principal and not the agent or fiduciary of the Company or the Guarantor, (iii) no Purchaser has assumed an advisory or fiduciary
responsibility in favor of the Company or the Guarantor with respect to the offering contemplated hereby or the process leading thereto
(irrespective of whether such Purchaser has advised or is currently advising the Company or the Guarantor on other matters) or any other
obligation to the Company or the Guarantor except the obligations expressly set forth in this Agreement and (iv) the Company and the Guarantor
have consulted their own legal and financial advisors to the extent it deemed appropriate. The Company and the Guarantor agrees that it
will not claim that the Purchaser, or any of them, has rendered advisory services of any nature or respect, or owes a fiduciary or similar
duty to the Company or the Guarantor, in connection with such transaction or the process leading thereto.



 


		17.	The Company and the Guarantor acknowledge that the Purchasers’ research analysts and research departments
are required to be independent from their respective investment banking divisions and are subject to certain regulations and internal
policies, and that such Purchasers’ research analysts may hold views and make statements or investment recommendations and/or publish
research reports with respect to the Company, Guarantor and/or the offering that differ from the views of their respective investment
banking divisions. The Company and the Guarantor hereby waive and release, to the fullest extent permitted by law, any claims that the
Company or the Guarantor may have against the Purchasers with respect to any conflict of interest that may arise from the fact that the
views expressed by their independent research analysts and research departments may be different from or inconsistent with the views or
advice communicated to the Company and the Guarantor by such Purchasers’ investment banking divisions. The Company and the Guarantor
acknowledge that each of the Purchasers is a full service securities firm and as such from time to time, subject to applicable securities
laws, may effect transactions for its own account or the account of its customers and hold long or short positions in debt or equity securities
of the companies that may be the subject of the transactions contemplated by this Agreement.



 


		18.	This Agreement supersedes all prior agreements and understandings (whether written or oral) among the
Company, the Guarantor and the Purchasers, or any of them, with respect to the subject matter hereof.



 


		19.	THIS AGREEMENT AND ANY MATTERS RELATED TO THIS TRANSACTION SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE
WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICT OF LAWS THAT WOULD RESULT IN THE APPLICATION OF ANY LAW
OTHER THAN THE LAWS OF THE STATE OF NEW YORK. The Company and the Guarantor agree that any suit or proceeding arising in respect of this
Agreement or your engagement will be tried exclusively in the U.S. District Court for the Southern District of New York or, if that court
does not have subject matter jurisdiction, in any state court located in The City and County of New York and the Company agrees to
submit to the jurisdiction of, and to venue in, such courts.



 


		20.	The Company, the Guarantor and each of the Purchasers hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement or
the transactions contemplated hereby.



 






    20


     


    

 


		21.	This Agreement may be executed by any one or more of the parties hereto in any number of counterparts,
each of which shall be deemed to be an original, but all such respective counterparts shall together constitute one and the same instrument.
Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act
of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com)
or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and
effective for all purposes.



 


		22.	Notwithstanding anything herein to the contrary, the Company and the Guarantor (and the Company’s
and the Guarantor’s employees, representatives, and other agents) are authorized to disclose to any and all persons, the tax treatment
and tax structure of the potential transaction and all materials of any kind (including tax opinions and other tax analyses) provided
to the Company or the Guarantor relating to that treatment and structure, without the Purchasers’ imposing any limitation of any
kind. However, any information relating to the tax treatment and tax structure shall remain confidential (and the foregoing sentence shall
not apply) to the extent necessary to enable any person to comply with securities laws. For this purpose, “tax treatment”
means US federal and state income tax treatment, and “tax structure” is limited to any facts that may be relevant to that
treatment.



 


		23.	If any term or other provision of this Agreement shall be held invalid, illegal or unenforceable, the
validity, legality or enforceability of the other provisions of this Agreement shall not be affected thereby, and there shall be deemed
substituted for the provision at issue a valid, legal and enforceable provision as similar as possible to the provision at issue.



 


		24.	In the event that any Purchaser that is a Covered Entity becomes
subject to a proceeding under a U.S. Special Resolution Regime, the transfer from such Purchaser of this Agreement, and any interest and
obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special
Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of
the United States.



 


In
the event that any Purchaser that is a Covered Entity or a BHC Act Affiliate of such Purchaser becomes subject to a proceeding under a
U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Purchaser are permitted to be exercised
to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed
by the laws of the United States or a state of the United States.


 


For
purposes of foregoing two paragraphs, “BHC Act Affiliate” has the meaning assigned to the term “affiliate”
in, and shall be interpreted in accordance with, 12 U.S.C. § 1841(k); “Covered Entity” means any of the following:
(i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b), (ii) a
“covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b) or (iii) a “covered
FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b); “Default Right”
has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as
applicable; and “U.S. Special Resolution Regime” means each of (i) the Federal Deposit Insurance Act and the regulations
promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated
thereunder.


 


		25.	Except as otherwise expressly provided herein, the provisions of this Agreement may be amended or waived
at any time only by the written agreement of the parties hereto. Any waiver, permit, consent or approval of any kind or character on the
part of any such holders of any provision or condition of this Agreement must be made in writing and shall be effective only to the extent
specifically set forth in writing. The failure of any party hereto to enforce at any time any provision of this Agreement shall not be
construed to be a waiver of such provision, nor in any way to affect the validity of this Agreement or any part hereof or the right of
any party thereafter to enforce each and every such provision. No waiver of any breach of this Agreement shall be held to constitute a
waiver of any other or subsequent breach.



 


If the foregoing is in accordance with your understanding,
please sign and return to us counterparts hereof, and upon the acceptance hereof by you, on behalf of each of the Purchasers, this letter
and such acceptance hereof shall constitute a binding agreement among each of the Purchasers, the Company and the Guarantor. It is understood
that your acceptance of this letter on behalf of each of the Purchasers is pursuant to the authority set forth in a form of Agreement
among Purchasers, the form of which shall be submitted to the Company for examination upon request, but without warranty on your part
as to the authority of the signers thereof.


 




    21


     


    

 


	 	Very truly yours,
	 	 
	 	Envestnet, Inc.
	 	 	 
	 	By:	/s/ William C. Crager 
	 	 	Name:	William C. Crager
	 	 	Title: Chief Executive Officer
	 	 	 
	 	Envestnet Asset Management, Inc.
	 	 	 
	 	By:	/s/ William C. Crager
	 	 	Name: 	 William C. Crager
	 	 	Title: Chief Executive Officer



 



    22


     


    

 


Accepted as of the date hereof:


 


	Morgan Stanley & Co. LLC	 
	 	 	 
	By:	/s/ Aditya Bhatia	 
	 	Name:	 Aditya Bhatia	 
	 	Title:	Vice President	 
	 	 	 
	BOFA Securities, Inc.	 
	 	 	 
	By:	/s/ Abbe Galvez Cordon	 
	 	Name:	Abbe Galvez Cordon	 
	 	Title:	Managing Director	 
	 	 	 
	BMO capital markets corp.	 
	 	 	 
	By:	/s/ Brian Riley	 
	 	Name: 	 Brian Riley	 
	 	Title:	 Managing Director, Global Markets	 
	 	 	 
	j.p. morgan securities llc	 
	 	 	 
	By:	/s/ Jim Izawa	 
	 	Name:	Jim Izawa	 
	 	Title:	Executive Director	 



 


For themselves and on behalf of each of the other
Purchasers.


 



    23


     


    

 





SCHEDULE I




 


	 	 	Principal Amount of	 	 	Principal 
 Amount of
 Optional
 Securities
 to be	 
	 	 	Firm
 Securities	 	 	Purchased
 if Maximum	 
	 	 	to be	 	 	Option	 
	Purchaser	 	Purchased	 	 	    Exercised	 
	Morgan Stanley & Co. LLC	 	$	155,000,000	 	 	$	23,250,000	 
	BofA Securities, Inc. 	 	 	91,666,000	 	 	 	13,750,000	 
	BMO Capital Markets Corp.	 	 	91,666,000	 	 	 	13,750,000	 
	J.P. Morgan Securities LLC	 	 	91,666,000	 	 	 	13,750,000	 
	JMP Securities LLC	 	 	11,667,000	 	 	 	1,750,000	 
	UBS Securities LLC	 	 	11,667,000	 	 	 	1,750,000	 
	Fifth Third Securities, Inc.	 	 	11,667,000	 	 	 	1,750,000	 
	Moelis & Company LLC 	 	 	11,667,000	 	 	 	1,750,000	 
	MUFG Securities Americas Inc.	 	 	11,667,000	 	 	 	1,750,000	 
	Piper Sandler & Co.	 	 	11,667,000	 	 	 	1,750,000	 
	Total	 	$	500,000,000	 	 	$	75,000,000	 




 






    Schedule I-1


     


    

 


SCHEDULE II


 


		(a)	Company Supplemental Disclosure Documents:



 


The Ecosystem For Financial
Wellness


Investor Presentation


November 14, 2022


 


		(b)	Purchaser Supplemental Disclosure Documents: None









 






    Schedule II-1


     


    

 


SCHEDULE
III


 


	PRICING TERM SHEET	STRICTLY CONFIDENTIAL
	Dated November 14, 2022	 



 


Envestnet, Inc.


 


2.625% Convertible Notes due 2027


 


The information in this pricing term sheet
relates to the offering (the “Offering”) by Envestnet, Inc. (the “Issuer”) of its 2.625% Convertible Notes due
2027 (the “Notes”) and should be read together with the preliminary offering memorandum dated November 14, 2022 (including
the documents incorporated by reference therein) relating to the Offering (the “Preliminary Offering Memorandum”). The information
in this pricing term sheet supplements the Preliminary Offering Memorandum and supersedes the information in the Preliminary Offering
Memorandum to the extent that it is inconsistent therewith. Terms used but not defined herein have the meanings ascribed to them in the
Preliminary Offering Memorandum.


 


The Notes and the shares of common stock issuable
upon conversion of the Notes, if any, have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities
Act”), or any other securities laws, and may not be offered or sold within the United States or any other jurisdiction, except pursuant
to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any other applicable
securities laws. Accordingly, the Notes are being offered only to persons reasonably believed to be “qualified institutional buyers”
(as defined in Rule 144A under the Securities Act).


 


	Issuer:	Envestnet,
    Inc. (NYSE: ENV)
	 	 
	Guarantor:	Envestnet Asset Management,
    Inc. 
	 	 
	Securities Offered:	2.625% Convertible Notes
    due 2027
	 	 
	Offering Size:	$500,000,000 aggregate
    principal amount (or $575,000,000 aggregate principal amount if the initial purchasers exercise their option to purchase additional
    Notes solely to cover over-allotments in full)
	 	 
	Offering Price:	100% of the principal amount,
    plus accrued interest, if any, from the Settlement Date
	 	 
	Use of Proceeds:	The
    Issuer estimates that the net proceeds from the sale of the Notes, after deducting the initial purchasers’ discounts and offering
    expenses, will be approximately $485.5 million or approximately $558.4 million assuming the initial purchasers exercise their option
    to purchase additional Notes in full. 
	 	 
	 	The
    Issuer intends to use a portion of the net proceeds from the sale of the Notes, together with cash on hand, to repurchase $300.0
    million in aggregate principal amount of its 1.75% convertible notes due 2023 for an aggregate of approximately $312.4 million plus
    accrued interest in cash and $200.0 million in aggregate principal amount of its 0.75% convertible notes due 2025 for an aggregate
    of approximately $181.8 million plus accrued interest in cash (collectively, the “convertible notes”) pursuant to separate
    and individually negotiated transactions with certain holders of the convertible notes. 



 






    Schedule III-1


     


    

 


	 	The
    Issuer has entered into capped call transactions with one or more of the initial purchasers or affiliates thereof and other financial
    institutions (collectively, the “option counterparties”). The Issuer expects to use approximately $69.1 million of the
    net proceeds from the sale of the Notes to pay the cost of the capped call transactions. 
	 	 
	 	If
    the initial purchasers exercise their option to purchase additional Notes, the Issuer may use a portion of the net proceeds from
    the sale of such additional Notes to enter into additional capped call transactions with the option counterparties, and the remaining
    net proceeds as described above.
	 	 
	 	The
    Issuer intends to use the remaining net proceeds, if any, for general corporate purposes, which may include selective strategic investments
    through acquisitions, alliances or other transactions. 
	 	 
	 	Pending
    application of the net proceeds as described above, the Issuer may invest the net proceeds in marketable securities or other investments.
    See “Use of Proceeds” in the Preliminary
    Offering Memorandum.
	 	 
	Trade Date:	November 15, 2022
	 	 
	Settlement Date:	November 17, 2022
	 	 
	Maturity:	December 1, 2027, unless
    earlier purchased, redeemed or converted
	 	 
	Interest Rate:	2.625% per year payable
    semi-annually in arrears in cash
	 	 
	Interest Payment Dates:	June 1 and December 1 of
    each year, beginning June 1, 2023 (long first interest period)
	 	 
	Optional Redemption:	The Issuer may not redeem
    the Notes prior to December 5, 2025. The Issuer may redeem for cash all or any portion of the Notes, at its option, on or after December
    5, 2025 if the last reported sale price of its common stock (the “Common Stock”) has been at least 130% of the conversion
    price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including
    the last trading day of such period) ending on, and including, any of the five trading days immediately preceding the date on which
    the Issuer provides notice of redemption, at a redemption price equal to 100% of the principal amount of the Notes to be redeemed,
    plus accrued and unpaid interest thereon, if any, to, but excluding, the redemption date. No sinking fund is provided for the Notes,
    which means that the Issuer is not required to redeem or retire the Notes periodically.
	 	 
	Fundamental Change:	If the Issuer undergoes
    a “fundamental change” (as defined in the Preliminary Offering Memorandum under the heading ‘‘Description
    of the Notes—Fundamental Change Permits Holders to Require Us to Purchase Notes’’) prior to maturity, subject to
    certain conditions, holders may require the Issuer to purchase all or any portion of their Notes in principal amounts of $1,000 or
    a multiple thereof. The fundamental change purchase price will be equal to 100% of the principal amount of the Notes to be purchased,
    plus any accrued and unpaid interest to, but excluding, the fundamental change purchase date. The Issuer will pay the fundamental
    change purchase price in cash. See “Description of the Notes—Fundamental Change Permits Holders to Require Us to Purchase
    Notes” in the Preliminary Offering Memorandum.



 






    Schedule III-2


     


    

 


	NYSE Last Reported
    Sale 

Price on November 14,
    2022:	$55.37 per share of the
    Common Stock
	 	 
	Initial Conversion Rate:	13.6304 shares of Common
    Stock per $1,000 principal amount of Notes
	 	 
	Initial Conversion Price:	Approximately $73.37 per
    share of Common Stock
	 	 
	Conversion Premium:	Approximately 32.5% above
    the NYSE Last Reported Sale Price on November 14, 2022
	 	 
	Adjustment to Conversion
    Rate 

upon Conversion in Connection

 with a Make-whole Fundamental 

Change or an Optional Redemption:	The following table sets
    forth the number of additional shares (as defined under “Description of the Notes—Adjustment to the Conversion Rate Upon
    Conversion in Connection with a Make-whole Fundamental Change or an Optional Redemption” in the Preliminary Offering Memorandum)
    to be received per $1,000 principal amount of Notes for each stock price and effective date or redemption notice date set forth below:


 


	 	 	Stock Price	 
	Effective Date/ Redemption Notice Date	 	$55.37	 	 	$65.00	 	 	$73.37	 	 	$85.00	 	 	$95.38	 	 	$125.00	 	 	$175.00	 	 	$250.00	 	 	$400.00	 	 	$600.00	 	 	$800.00	 	 	$1,000.00	 
	November 17, 2022	 	 	4.4299	 	 	 	3.2555	 	 	 	2.5699	 	 	 	1.9273	 	 	 	1.5423	 	 	 	0.9322	 	 	 	0.5231	 	 	 	0.2906	 	 	 	0.1205	 	 	 	0.0388	 	 	 	0.0084	 	 	 	0.0000	 
	December 1, 2023	 	 	4.4299	 	 	 	3.1777	 	 	 	2.4405	 	 	 	1.7682	 	 	 	1.3787	 	 	 	0.7942	 	 	 	0.4351	 	 	 	0.2429	 	 	 	0.1021	 	 	 	0.0326	 	 	 	0.0065	 	 	 	0.0000	 
	December 1, 2024	 	 	4.4299	 	 	 	3.0255	 	 	 	2.2324	 	 	 	1.5362	 	 	 	1.1524	 	 	 	0.6210	 	 	 	0.3335	 	 	 	0.1890	 	 	 	0.0807	 	 	 	0.0254	 	 	 	0.0043	 	 	 	0.0000	 
	December 1, 2025	 	 	4.4299	 	 	 	2.7538	 	 	 	1.9000	 	 	 	1.1966	 	 	 	0.8410	 	 	 	0.4133	 	 	 	0.2226	 	 	 	0.1297	 	 	 	0.0561	 	 	 	0.0172	 	 	 	0.0020	 	 	 	0.0000	 
	December 1, 2026	 	 	4.4299	 	 	 	2.3446	 	 	 	1.3943	 	 	 	0.7141	 	 	 	0.4367	 	 	 	0.1928	 	 	 	0.1112	 	 	 	0.0670	 	 	 	0.0293	 	 	 	0.0087	 	 	 	0.0004	 	 	 	0.0000	 
	December 1, 2027	 	 	4.4299	 	 	 	1.7542	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 	 	 	0.0000	 




 


	 	The
    exact stock prices and effective dates or redemption notice dates may not be set forth in the table above, in which case:



 


		●	If
the stock price is between two stock prices in the table or the effective date or redemption notice date is between two dates in the
table, the number of additional shares will be determined by a straight-line interpolation between the number of additional shares set
forth for the higher and lower stock prices and the earlier and later effective dates, as applicable, based on a 365-day year.



 


		●	If
the stock price is greater than $1,000.00 per share (subject to adjustment in the same manner as the stock prices set forth in the column
headings of the table above), no additional shares will be added to the conversion rate.



 


		●	If
the stock price is less than $55.37 per share (subject to adjustment in the same manner as the stock prices set forth in the column headings
of the table above), no additional shares will be added to the conversion rate.



 






    Schedule III-3


     


    

 


	 	Notwithstanding
    the foregoing, in no event will the conversion rate exceed 18.0603
    shares per $1,000 principal amount of Notes, subject to adjustment in the same manner as the
    conversion rate as set forth under “Description of the Notes—Conversion Rate Adjustments” in the Preliminary
    Offering Memorandum.
	 	 
	CUSIP/ISIN:	29404K AF3 / US29404KAF30
	 	 
	Joint Book-Running Managers:	Morgan
    Stanley & Co. LLC
	 	BofA
    Securities, Inc.
	 	BMO
    Capital Markets Corp.
	 	J.P.
    Morgan Securities LLC
	 	JMP Securities LLC
	 	UBS
    Securities LLC
	 	 
	Co-Managers:	Fifth Third Securities,
    Inc.
	 	Moelis & Company LLC
	 	MUFG Securities Americas
    Inc.
	 	Piper Sandler & Co.


 


Modification
to Conversion Period and Related Terms


 


The
“conversion period” for the Notes during which settlement amounts due upon conversion may be determined will be 60 consecutive
trading days instead of 50 consecutive trading days as described in the Preliminary Offering Memorandum. Accordingly, the following changes
to the definition of the term “conversion period” and related changes to the terms of the Notes described under “Description
of the Notes” in the Preliminary Offering Memorandum in order to effect this modification are described below. Defined terms used
below shall have the respective meanings set forth in the Preliminary Offering Memorandum.


 


Settlement
amounts will be computed as follows:


 


		●	if
                                            we elect to satisfy our conversion obligation through stock settlement, we will deliver to
                                            the converting holder in respect of each $1,000 principal amount of notes being converted
                                            a number of shares of our common stock equal to the conversion rate in effect on the conversion
                                            date (together with cash in lieu of fractional shares);



 


		●	if
                                            we elect to satisfy our conversion obligation through cash settlement, we will pay to the
                                            converting holder in respect of each $1,000 principal amount of notes being converted cash
                                            in an amount equal to the sum of the daily conversion values (as defined below) for each
                                            of the 60 consecutive trading days during the related conversion period; and



 


		●	if
                                            we elect (or are deemed to have elected) to satisfy our conversion obligation through combination
                                            settlement, we will deliver to holders in respect of each $1,000 principal amount of notes
                                            being converted a settlement amount equal to the sum of the daily settlement amounts (as
                                            defined below) for each of the 60 consecutive trading days during the related conversion
                                            period.



 


“Conversion
period” with respect to the Notes means:


 


		●	if
                                            the relevant conversion date occurs prior to the 65th scheduled trading day prior to the
                                            maturity date, the 60 consecutive trading day period beginning on, and including, the second
                                            trading day immediately following the related conversion date;



 


		●	if
                                            the relevant conversion date occurs on or after the date of our issuance of a notice of redemption
                                            with respect to the notes as described under “—Optional Redemption” in
                                            the Preliminary Offering Memorandum and prior to the redemption date, the 60 consecutive
                                            trading days beginning on, and including, the 61st scheduled trading day immediately preceding
                                            such redemption date; and



 






    Schedule III-4


     


    

 


		●	if
                                            the relevant conversion date occurs on or after the final settlement method election date,
                                            the 60 consecutive trading day period beginning on, and including, the 61st scheduled trading
                                            day immediately preceding the maturity date.



 


The
“daily settlement amount,” for each $1,000 aggregate principal amount of notes validly surrendered for conversion, and for
each trading day during the conversion period, will consist of:


 


		(1)	cash
                                            equal to the lesser of (i) a dollar amount per $1,000 principal amount of notes to be received
                                            upon conversion as specified by us in the notice regarding our chosen settlement method (the
                                            “specified dollar amount”), if any, divided by 60 (such quotient being referred
                                            to as the “daily measurement value”) and (ii) the daily conversion value; and



 


		(2)	to
                                            the extent the daily conversion value exceeds the daily measurement value, a number of shares
                                            equal to (i) the difference between the daily conversion value and the daily measurement
                                            value, divided by (ii) the daily VWAP of our common stock for such trading day.



 


“Daily
conversion value” means, for each trading day during the conversion period, one-sixtieth (1/60th) of the product of (i) the conversion
rate on such trading day and (ii) the daily VWAP of our common stock on such trading day.


 


As
described under “Description of the Notes—Optional Redemption,” in the case of any optional redemption, we will provide
not less than 70 nor more than 90 scheduled trading days’ notice before the redemption date to the trustee, the paying agent and
each holder of notes, and the redemption price will be equal to 100% of the principal amount of the notes to be redeemed, plus accrued
and unpaid interest thereon, if any, to, but excluding, the redemption date (unless the redemption date falls after a regular record
date but on or prior to the immediately succeeding interest payment date, in which case we will pay the full amount of such accrued and
unpaid interest to the holder of record as of the close of business on such regular record date, and the redemption price will be equal
to 100% of the principal amount of the notes to be redeemed).


 


In
connection with an issuance or distribution described in the bullet points under the caption “Description of the Notes—Conversion
Rights—Conversion upon Specified Corporate Events—Conversion upon Certain Distributions,” we must notify holders (with
a copy to the trustee and conversion agent) at least 70 scheduled trading days prior to the ex-dividend date for such distribution. Once
we have given such notice, holders may surrender their notes for conversion at any time until the earlier of the close of business on
the business day immediately preceding the ex-dividend date and our announcement that such issuance or distribution will not take place.


 


*
* *


 


This
pricing term sheet is intended for the sole use of the person to whom it is provided by the sender. This pricing term sheet is confidential
and is for your information only and is not intended to be used by anyone other than you. The information in this pricing term sheet
does not purport to be a complete description of the Notes or the Offering. This pricing term sheet does not constitute an offer to sell
or the solicitation of an offer to buy any Notes in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation
in such jurisdiction. 


 


The
Notes and any shares of Common Stock issuable upon conversion of the Notes are not transferable except in accordance with the restrictions
described under “Transfer Restrictions” in the Preliminary Offering Memorandum.


 


A
copy of the Preliminary Offering Memorandum may be obtained by contacting Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor,
New York, NY 10014, Attention: Prospectus Department, by telephone at (866) 718-1649 or by email at prospectus@morganstanley.com; BofA
Securities, NC1-004-03-43, 200 North College Street, 3rd floor, Charlotte, NC 28255-0001, Attn: Prospectus Department, or by email at:
dg.prospectus_requests@bofa.com; BMO Capital Markets Corp., Attention: Equity Syndicate Department, 151 W. 42nd Street, 32nd Floor, New
York, NY 10036, by email at bmoprospectus@bmo.com, or by phone at (800) 414-3627; or J.P. Morgan Securities LLC, c/o, Broadridge Financial
Solutions, 1155 Long Island Avenue, Edgewood, New York 11717 or by telephone at (866) 803-9204.


 


ANY
LEGENDS, DISCLAIMERS OR OTHER NOTICES THAT MAY APPEAR BELOW ARE NOT APPLICABLE TO THIS COMMUNICATION AND SHOULD BE DISREGARDED. SUCH
DISCLAIMERS OR OTHER NOTICES WERE AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT VIA BLOOMBERG OR ANOTHER EMAIL
SYSTEM


 






    Schedule III-5


     


    

 


SCHEDULE
IV

 


[PROVIDED
SEPARATELY]


 




    Schedule IV-1


     


    

 


ANNEX
I


 


[PROVIDED
SEPARATELY]


 




     Annex I-1


     


    

 


ANNEX
II


 


[PROVIDED
SEPARATELY]


 




     Annex II-1


     


    

 


ANNEX
III


 


[_________],
2022


 


Morgan
Stanley & Co. LLC


1585
Broadway


New
York, New York 10036


 


BMO
Capital Markets Corp.


3
Times Square, 25th Floor


New
York, New York 10036


 


BofA
Securities, Inc.


One
Bryant Park


New
York, New York 10036


 


J.P.
Morgan Securities LLC

383 Madison Avenue

New York, New York 10179


 


As
representatives of the several initial purchasers


 


Ladies
and Gentlemen:


 


The
undersigned understands that Morgan Stanley & Co. LLC, BMO Capital Markets Corp., BofA Securities, Inc. and J.P. Morgan Securities
LLC (collectively, the “Representatives”) propose to enter into a Purchase Agreement (the “Purchase Agreement”)
with Envestnet, Inc. (the “Company”) providing for the offering (the “Offering”) by the several initial purchasers,
including the Representatives named therein (the “Initial Purchasers”), of the Company’s convertible notes.


 


In
order to induce the Initial Purchasers to enter into the Purchase Agreement and to participate in the Offering, the undersigned hereby
irrevocably agrees that, without the prior written consent of the Representatives, he or she will not, during the period commencing on
the date hereof and continuing to and including the date 60 days after the date of the final offering memorandum relating to the Offering
(the “Restricted Period”), (1) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any
option or contract to sell, grant any option, right or warrant to purchase, lend, pledge, hypothecate or otherwise transfer or dispose
of, directly or indirectly, any shares of common stock, par value $0.005 per share, of the Company (“Common Stock”) beneficially
owned (as such term is used in Rule 13d-3 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), by
the undersigned or any other securities so owned convertible into or exercisable or exchangeable for Common Stock or (2) enter into
any swap, hedge or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of
the Common Stock or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled
by delivery of Common Stock or such other securities, in cash or otherwise.


 






     Annex III-1


     


    

 


The
restrictions contained in the preceding paragraph shall not apply to (a) transactions by the undersigned relating to shares of Common
Stock or other securities acquired in open market transactions after the completion of the Offering, provided that no
filing under Section 16(a) of the Exchange Act shall be required or shall be voluntarily made during the Restricted Period in connection
with subsequent sales of Common Stock or other securities acquired in such open market transactions; (b) transfers by the undersigned
of shares of Common Stock or any security convertible into Common Stock as a bona fide gift or charitable contribution; (c) distributions
by the undersigned of shares of Common Stock or any security convertible into Common Stock to limited partners or stockholders of the
undersigned; (d) the establishment of a trading plan pursuant to Rule 10b5-1 under the Exchange Act (a “10b5-1 Plan”) for
the transfer of shares of Common Stock, provided that such 10b5-1 Plan does not provide for the transfer of Common Stock
during the Restricted Period and no public announcement or filing under the Exchange Act regarding the establishment of such 10b5-1 Plan
shall be required of or voluntarily made by or on behalf of the undersigned during the Restricted Period; (e) transfers of shares
of Common Stock to family members of, and other persons sharing a household with, the undersigned in connection with personal estate
planning matters; provided that in the case of any transfer or distribution pursuant to clause (b), (c), or (e),
(A) the donee, distributee or transferee shall enter into a written agreement, satisfactory to the Representatives, pursuant to
which the donee, distributee or transferee shall agree to receive and hold such shares of Common Stock or security convertible into Common
Stock subject to the provisions hereof and (B) no filing under Section 16(a) of the Exchange Act, reporting a reduction in
beneficial ownership of shares of Common Stock, shall be required or shall be voluntarily made in respect of the transfer or distribution
during the Restricted Period; (f) the exercise of options granted under the Company’s equity-based incentive plans, provided
that the shares of Common Stock delivered upon such exercise are subject to the restrictions set forth in the forgoing sentence;
(g) the surrender or forfeiture of shares of Common Stock to the Company in a transaction exempt from Section 16(b) of the Exchange Act
to satisfy tax withholding obligations upon exercise or vesting of stock options, restricted stock awards or similar equity awards; (h) transfers
of shares of Common Stock to the Company in connection with the cashless exercise of options that would otherwise expire, other than
a “broker-assisted” cashless exercise; provided that, for the avoidance of doubt, any shares of Common Stock
received in connection with the cashless exercise of options shall be subject to the restrictions set forth in the preceding paragraph;
or (i) sales of Common Stock under 10b5-1 Plans in existence on the date hereof, provided that any filing under the Exchange Act as a
result of such sale under this clause (i) shall include a footnote stating that such sale was made pursuant to an existing 10b5-1 Plan.
For purposes of this paragraph, “family members” shall mean the spouse, lineal descendant (including adopted and “step”
lineal descendants), father, mother, brother or sister of the transferor. In addition, the undersigned agrees that, without the prior
written consent of the Representatives, he, she or it will not, during the Restricted Period, make any demand for, or exercise any right
with respect to, the registration of any shares of Common Stock or any security convertible into or exercisable or exchangeable for Common
Stock, other than in connection with the Offering.


 


In
addition, the undersigned consents to the entry of stop transfer instructions with the Company’s transfer agent and registrar against
the transfer of any shares of Common Stock held by the undersigned, except in compliance with this agreement.


 


The
undersigned acknowledges and agrees that the Initial Purchasers have not provided any recommendation or investment advice nor have the
Initial Purchasers solicited any action from the undersigned with respect to the Offering and the undersigned has consulted their own
legal, accounting, financial, regulatory and tax advisors to the extent deemed appropriate. The undersigned further acknowledges and
agrees that, although the Representatives may be required or choose to provide certain Regulation Best Interest and Form CRS disclosures
to you in connection with the Offering, the Representatives and the other Initial Purchasers are not making a recommendation to you to
enter into this agreement, and nothing set forth in such disclosures is intended to suggest that the Representatives or any Initial Purchaser
is making such a recommendation.


 


The
undersigned understands that the Company and the Initial Purchasers are relying upon this agreement in proceeding toward consummation
of the Offering. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned’s
heirs, legal representatives, successors and assigns. It is understood, however, that if the Company notifies you, prior to the execution
of the Purchase Agreement, that it does not intend to proceed with the Offering or if the Purchase Agreement is terminated then this
agreement shall terminate.


 


[Signature
Page Follows]


 






     Annex III-2


     


    

 


	 	Very truly yours,
	 	 
	Dated: ______________, 2022	 
	 	Signature
	 	 
	 	 
	 	Name and Title



 


 


Annex
III-3